Two Sigma Advisers LP Invests $625,000 in Tempus AI, Inc. (NASDAQ:TEM)

Two Sigma Advisers LP purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 18,500 shares of the company’s stock, valued at approximately $625,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ProShare Advisors LLC bought a new position in Tempus AI during the fourth quarter valued at approximately $244,000. Lazard Asset Management LLC bought a new position in Tempus AI during the fourth quarter valued at approximately $1,034,000. Frontier Capital Management Co. LLC boosted its stake in Tempus AI by 236.2% during the fourth quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company’s stock valued at $31,860,000 after buying an additional 663,018 shares during the last quarter. Circle Wealth Management LLC bought a new position in Tempus AI during the fourth quarter valued at approximately $253,000. Finally, Crestline Management LP bought a new position in Tempus AI during the fourth quarter valued at approximately $675,000. 24.22% of the stock is owned by institutional investors.

Insider Transactions at Tempus AI

In related news, Director David R. Epstein sold 990 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $46.83, for a total value of $46,361.70. Following the transaction, the director now owns 26,284 shares of the company’s stock, valued at $1,230,879.72. This represents a 3.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Andrew Polovin sold 13,135 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total value of $603,947.30. Following the completion of the transaction, the executive vice president now directly owns 154,171 shares in the company, valued at approximately $7,088,782.58. This trade represents a 7.85% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 139,888 shares of company stock worth $7,938,111. 27.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently commented on TEM. JPMorgan Chase & Co. lowered Tempus AI from an “overweight” rating to a “neutral” rating and increased their price target for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. BTIG Research began coverage on Tempus AI in a research note on Monday, April 21st. They set a “buy” rating and a $60.00 price target for the company. William Blair restated a “market perform” rating on shares of Tempus AI in a research report on Tuesday, February 25th. TD Cowen restated a “buy” rating and set a $74.00 price objective (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Finally, Guggenheim restated a “buy” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $63.42.

Tempus AI Trading Down 2.4%

Shares of NASDAQ TEM opened at $61.96 on Wednesday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The business’s 50 day moving average price is $52.48 and its 200-day moving average price is $51.90. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $91.45. The company has a market cap of $10.73 billion and a price-to-earnings ratio of -7.94.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analysts’ expectations of $248.13 million. The company’s revenue for the quarter was up 75.4% compared to the same quarter last year. On average, sell-side analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.